1. CMV seropositivity and T-cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study
- Author
-
John D. Isaacs, Mohammad E Yadegarfar, Carmen Martin-Ruiz, Thomas B. L. Kirkwood, Carol Jagger, Catharien M. U. Hilkens, Ioakim Spyridopoulos, and Thomas von Zglinicki
- Subjects
Male ,0301 basic medicine ,Senescence ,Aging ,medicine.medical_specialty ,octogenarians ,T-Lymphocytes ,T cell ,T lymphocytes ,survival ,Gastroenterology ,03 medical and health sciences ,Internal medicine ,medicine ,Humans ,Myocardial infarction ,coronary heart disease ,cytomegalovirus ,Survival rate ,Stroke ,immunosenescence ,Aged, 80 and over ,Proportional hazards model ,business.industry ,Incidence (epidemiology) ,Age Factors ,Short Take ,CD8 ,Cell Biology ,medicine.disease ,CD4 ,United Kingdom ,030104 developmental biology ,medicine.anatomical_structure ,Cardiovascular Diseases ,Chronic Disease ,Cytomegalovirus Infections ,Immunology ,Female ,business - Abstract
Summary Although chronic infection with cytomegalovirus (CMV) is known to drive T lymphocytes toward a senescent phenotype, it remains controversial whether and how CMV can cause coronary heart disease (CHD). To explore whether CMV seropositivity or T‐cell populations associated with immunosenescence were informative for adverse cardiovascular outcome in the very old, we prospectively analyzed peripheral blood samples from 751 octogenarians (38% males) from the Newcastle 85+ study for their power to predict survival during a 65‐month follow‐up (47.3% survival rate). CMV‐seropositive participants showed a higher prevalence of CHD (37.7% vs. 26.7%, P = 0.030) compared to CMV‐seronegative participants together with lower CD4/CD8 ratio (1.7 vs. 4.1, P
- Published
- 2015
- Full Text
- View/download PDF